Presentation of Copaxone 40 of Teva

Grupo EDT > Presentation of Copaxone 40 of Teva
Convención Teva 2015 1
Convención Teva 2015 2
Convención Teva 2015 3
Convención Teva 2015 4
Convención Teva 2015 5
Convención Teva 2015 6

Presentation of Copaxone 40 of Teva

The Challenge

Launch TEVA’s COPAXONE 40 mg/ml three times a week, a solution to enable adults with Recurrent Multiple Sclerosis to reduce the number of injections by almost 60%.


The Solution

A product presentation in front of more than 50 specialists. Different functional spaces with their own settings were designed: a careful scenography served to publicize the drug, while open spaces were used to promote the exchange of opinions about the product.


February 23, 2016


Events, Communication


4 July